SS Innovations International (NASDAQ:SSII) Stock Price Up 8.8% – Time to Buy?

SS Innovations International, Inc. (NASDAQ:SSIIGet Free Report)’s stock price rose 8.8% on Tuesday . The company traded as high as $4.85 and last traded at $5.2350. Approximately 5,954 shares traded hands during trading, a decline of 93% from the average daily volume of 90,754 shares. The stock had previously closed at $4.81.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings restated a “sell (e+)” rating on shares of SS Innovations International in a report on Thursday, January 22nd. One investment analyst has rated the stock with a Sell rating, According to data from MarketBeat, SS Innovations International has an average rating of “Sell”.

Check Out Our Latest Research Report on SS Innovations International

SS Innovations International Stock Performance

The business’s 50 day moving average is $4.55 and its 200 day moving average is $5.84. The stock has a market cap of $966.11 million and a price-to-earnings ratio of -82.83.

SS Innovations International (NASDAQ:SSIIGet Free Report) last posted its quarterly earnings data on Tuesday, March 10th. The company reported ($0.01) EPS for the quarter. SS Innovations International had a negative return on equity of 30.23% and a negative net margin of 28.54%.The firm had revenue of $14.53 million during the quarter.

Insider Buying and Selling

In other news, Director Timothy P. Adams acquired 300,000 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average price of $3.99 per share, with a total value of $1,197,000.00. Following the purchase, the director owned 5,331,902 shares of the company’s stock, valued at approximately $21,274,288.98. This trade represents a 5.96% increase in their position. The purchase was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, Director Frederic H. Moll acquired 501,253 shares of the firm’s stock in a transaction that occurred on Friday, March 6th. The stock was purchased at an average cost of $3.99 per share, with a total value of $1,999,999.47. Following the purchase, the director directly owned 10,775,485 shares in the company, valued at approximately $42,994,185.15. This trade represents a 4.88% increase in their position. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders bought 1,300,006 shares of company stock valued at $5,196,999.

Institutional Investors Weigh In On SS Innovations International

A number of institutional investors have recently modified their holdings of SSII. Geode Capital Management LLC acquired a new stake in shares of SS Innovations International during the 2nd quarter valued at $122,000. Inspire Investing LLC acquired a new stake in shares of SS Innovations International during the 3rd quarter valued at $240,000. Envestnet Asset Management Inc. acquired a new stake in shares of SS Innovations International during the 3rd quarter valued at $71,000. PNC Financial Services Group Inc. acquired a new stake in shares of SS Innovations International during the 3rd quarter valued at $56,000. Finally, Handelsbanken Fonder AB acquired a new stake in shares of SS Innovations International during the 3rd quarter valued at $714,000.

About SS Innovations International

(Get Free Report)

AVRA Medical Robotics, Inc develops and manufactures medical surgical devices. The company has a research agreement with the University of Central Florida to develop navigation and control technologies with applications in medical robotics. The company was formerly known as AVRA Surgical Microsystems, Inc and changed its name to AVRA Medical Robotics, Inc in November 2015. AVRA Medical Robotics, Inc was founded in 2015 and is based in Orlando, Florida.

Recommended Stories

Receive News & Ratings for SS Innovations International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SS Innovations International and related companies with MarketBeat.com's FREE daily email newsletter.